- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Combination immunotherapy: a road map ; volume:5 ; number:1 ; day:21 ; month:2 ; year:2017 ; pages:1-15 ; date:12.2017
Journal for ImmunoTherapy of Cancer ; 5, Heft 1 (21.2.2017), 1-15, 12.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Ott, Patrick A.
- Contributor
-
Hodi, F. Stephen
Kaufman, Howard L.
Wigginton, Jon M.
Wolchok, Jedd D.
SpringerLink (Online service)
- DOI
-
10.1186/s40425-017-0218-5
- URN
-
urn:nbn:de:1111-2017030515013
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ott, Patrick A.
- Hodi, F. Stephen
- Kaufman, Howard L.
- Wigginton, Jon M.
- Wolchok, Jedd D.
- SpringerLink (Online service)
Other Objects (12)
Combination Immunotherapy Strategies in Breast Cancer
Boar Road Map
Immunotherapy for glioblastoma: the promise of combination strategies
A target-agnostic combination immunotherapy synergistically cures established tumors
Combination strategies to maximize the benefits of cancer immunotherapy
Mechanisms, combination therapy, and biomarkers in cancer immunotherapy resistance
Project logistics road map
Combination immunotherapy overcomes resistance in MHC class I-deficient cancer
Cancer immunotherapy: avoiding the road to perdition
Synergistic immunotherapy targeting cancer-associated anemia: prospects of a combination strategy
Durvalumab Plus Tremelimumab: A Novel Combination Immunotherapy for Unresectable Hepatocellular Carcinoma
Macrophage-Based Combination Therapies as a New Strategy for Cancer Immunotherapy
Combination Immunotherapy Strategies in Breast Cancer
Boar Road Map
Immunotherapy for glioblastoma: the promise of combination strategies
A target-agnostic combination immunotherapy synergistically cures established tumors
Combination strategies to maximize the benefits of cancer immunotherapy
Mechanisms, combination therapy, and biomarkers in cancer immunotherapy resistance
Project logistics road map
Combination immunotherapy overcomes resistance in MHC class I-deficient cancer
Cancer immunotherapy: avoiding the road to perdition
Synergistic immunotherapy targeting cancer-associated anemia: prospects of a combination strategy
Durvalumab Plus Tremelimumab: A Novel Combination Immunotherapy for Unresectable Hepatocellular Carcinoma
Macrophage-Based Combination Therapies as a New Strategy for Cancer Immunotherapy
Combination Immunotherapy Strategies in Breast Cancer
Boar Road Map
Immunotherapy for glioblastoma: the promise of combination strategies
A target-agnostic combination immunotherapy synergistically cures established tumors
Combination strategies to maximize the benefits of cancer immunotherapy
Mechanisms, combination therapy, and biomarkers in cancer immunotherapy resistance
Project logistics road map
Combination immunotherapy overcomes resistance in MHC class I-deficient cancer
Cancer immunotherapy: avoiding the road to perdition
Synergistic immunotherapy targeting cancer-associated anemia: prospects of a combination strategy
Durvalumab Plus Tremelimumab: A Novel Combination Immunotherapy for Unresectable Hepatocellular Carcinoma